Uremic Toxins in the ICU: Patients After Cardiac Surgery
Not Applicable
Completed
- Conditions
- Renal Failure
- Registration Number
- NCT00752804
- Lead Sponsor
- University Hospital, Ghent
- Brief Summary
Study of the kinetics of uremic toxins in the ICU patients with acute renal failure, in order to optimize the dialysis dose: patients after cardiac surgery.The sampling of blood and dialysate will be done during dialyses with different durations (4, 6 and 8h)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
- ICU patients after cardiac surgery with acute renal failure
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Toxin removal During dialysis
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of uremic toxins are studied in NCT00752804 post-cardiac surgery ICU patients?
How does varying dialysis duration (4, 6, 8h) impact uremic toxin clearance in acute renal failure patients?
Which biomarkers correlate with dialysis efficacy in optimizing toxin removal for post-cardiac surgery acute kidney injury?
What adverse events are associated with extended dialysis protocols in ICU patients with acute renal failure?
Are there combination therapies or alternative approaches to uremic toxin management in acute kidney injury compared to standard dialysis in NCT00752804?
Trial Locations
- Locations (1)
University Hospital Ghent
🇧🇪Ghent, Belgium
University Hospital Ghent🇧🇪Ghent, Belgium